Immune Thrombocytopenic Purpura (ITP)

What is Immune thrombocytopenic purpura?

Immune thrombocytopenic purpura (ITP), also called immune thrombocytopenia, is an acquired disorder in which the immune system mistakenly attacks and destroys platelets – the tiny blood‑cell fragments that help blood clot. The resulting low platelet count (thrombocytopenia) can lead to easy bruising, petechiae (tiny red spots on the skin), and bleeding that may be difficult to stop.

ITP can be primary (no identifiable trigger) or secondary (linked to another condition, medication, or infection). While children often develop acute, self‑limited ITP that resolves within weeks, adults more frequently experience a chronic form that may require long‑term management.

Common Causes

In many cases the exact trigger remains unknown, but the following conditions are recognized as potential precipitating factors for secondary ITP:

• Viral infections: HIV, hepatitis C, Epstein‑Barr virus, and recently SARS‑CoV‑2.
• Bacterial infections: Helicobacter pylori, Mycoplasma pneumoniae.
• Medications: Heparin, quinine, certain antibiotics (e.g., ceftriaxone), and antiepileptics.
• Autoimmune diseases: Systemic lupus erythematosus, rheumatoid arthritis, Sjögren’s syndrome.
• Vaccinations: Rarely, vaccines (e.g., MMR, influenza) have been temporally associated with ITP.
• Lymphoproliferative disorders: Chronic lymphocytic leukemia, non‑Hodgkin lymphoma.
• Pregnancy: Hormonal and immunologic changes can trigger ITP in susceptible women.
• Genetic predisposition: Certain HLA types may increase susceptibility.
• Other hematologic conditions: Aplastic anemia, myelodysplastic syndromes.
• Idiopathic: Approximately 50‑70 % of adult cases have no identifiable cause.

Associated Symptoms

Because platelets are essential for clot formation, low counts manifest as bleeding‑related signs. Common symptoms include:

• Petechiae – pinpoint red or purple spots, usually on the lower legs.
• Purpura – larger bruises that appear without obvious trauma.
• Epistaxis – frequent or prolonged nosebleeds.
• Bleeding gums, especially after brushing.
• Heavy menstrual periods (menorrhagia) in women.
• Prolonged bleeding from minor cuts.
• Occasional blood in urine or stool (rare).
• Fatigue or weakness (often related to anemia from chronic bleeding).

When to See a Doctor

Any new or worsening bleeding signs should prompt a medical evaluation, especially if you have a known platelet disorder. Seek care promptly if you notice:

• Unexplained bruises larger than a penny.
• Petechiae that spread or appear on the face, trunk, or mucous membranes.
• Nosebleeds lasting longer than 15 minutes.
• Bleeding gums that do not stop after applying pressure.
• Blood in urine, stool, or vomit.
• Heavy or prolonged menstrual bleeding that interferes with daily activities.
• Sudden, severe headache or neurological changes (possible intracranial bleed).

Diagnosis

Diagnosing ITP is largely a process of exclusion—ruling out other causes of thrombocytopenia.

1. Medical History & Physical Exam

The clinician will ask about recent infections, medications, vaccinations, family history of bleeding disorders, and any systemic autoimmune disease.

2. Laboratory Tests

• Complete blood count (CBC): Confirms low platelet count; usually normal white‑blood‑cell and red‑blood‑cell numbers.
• Peripheral blood smear: Looks for abnormal platelet morphology or signs of leukemia.
• Coagulation profile (PT/INR, aPTT): Usually normal in ITP, helping rule out clotting factor deficiencies.
• HIV, hepatitis C, and Helicobacter pylori testing: Identifies infectious triggers.
• Autoimmune panel: ANA, dsDNA, rheumatoid factor if lupus or other autoimmune disease is suspected.

3. Bone Marrow Examination

Reserved for atypical cases (e.g., age > 60 y, pancytopenia, or suspicion of marrow infiltrative disease). Findings in ITP typically show normal or increased megakaryocytes, indicating peripheral destruction rather than production failure.

4. Imaging

Ultrasound or CT may be ordered if an organomegaly or tumor is suspected as an underlying cause.

Treatment Options

Treatment decisions depend on platelet count, severity of bleeding, and patient factors (age, comorbidities, pregnancy). Many patients with platelet counts > 30 × 10⁹/L and no bleeding can be observed without medication.

First‑Line (Acute) Therapies

• Corticosteroids: Prednisone 1 mg/kg daily or dexamethasone 40 mg daily for 4 days. Works by suppressing antibody production.
• Intravenous immune globulin (IVIG): 1 g/kg for 1–2 days; useful when a rapid platelet rise is needed (e.g., before surgery).
• Anti‑D immunoglobulin: For Rh‑positive, non‑splenectomized patients; binds to red cells and distracts the immune system.

Second‑Line (Chronic) Therapies

• Rituximab: Anti‑CD20 monoclonal antibody—used when steroids fail or are contraindicated.
• Thrombopoietin receptor agonists (TPO‑RAs):
  • Eltrombopag (oral)
  • Romiplostim (subcutaneous)
  These stimulate platelet production and have become standard for chronic ITP.
• Splenectomy: Historically the definitive therapy; now reserved for refractory cases because of infection risk.
• Immunosuppressants: Mycophenolate mofetil, azathioprine, or cyclosporine in select patients.

Supportive & Home Measures

• Avoid medications that impair platelet function (aspirin, NSAIDs, warfarin) unless directed by a doctor.
• Use a soft toothbrush and dental floss to limit gum bleeding.
• Apply firm pressure to minor cuts; use antiseptic dressings.
• Wear protective gear for high‑impact activities to reduce trauma.
• Maintain a balanced diet rich in vitamins K and C, which support vascular integrity.

Prevention Tips

Because many cases are idiopathic, complete prevention isn’t possible, but you can lower the risk of secondary ITP or exacerbations:

• Stay up‑to‑date with vaccinations; discuss any concerns with your provider.
• Practice safe sex and avoid needle sharing to reduce HIV/hepatitis risk.
• Promptly treat chronic infections such as H. pylori.
• Inform healthcare professionals about any previous drug reactions; keep an updated medication list.
• For women planning pregnancy, discuss ITP management with a hematologist and obstetrician.
• Regular follow‑up blood counts if you have a known chronic ITP diagnosis.

Emergency Warning Signs

Key Take‑aways

Immune thrombocytopenic purpura is an autoimmune condition that lowers platelet counts, leading to easy bruising and bleeding. While many patients respond to first‑line steroids or IVIG, chronic cases may require newer agents such as thrombopoietin receptor agonists or even splenectomy. Prompt recognition of warning signs and regular monitoring are essential to prevent serious complications. Always discuss treatment choices with a hematologist or your primary care provider, and seek urgent care if you notice any of the red‑flag symptoms listed above.

References: Mayo Clinic. “Immune thrombocytopenic purpura (ITP).” 2024; Centers for Disease Control and Prevention. “ITP and infections.” 2023; National Institutes of Health. “ITP guidelines.” 2024; American Society of Hematology. “Management of ITP.” 2023; WHO. “Bleeding disorders.” 2022.